KLRS – kalaris therapeutics, inc. (US:NASDAQ)

News

Kalaris Therapeutics (KLRS) is now covered by Morgan Stanley. They set an "overweight" rating on the stock.
Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates
Kalaris Therapeutics (KLRS) was upgraded by Wall Street Zen from "sel
Kalaris Therapeutics (NASDAQ:KLRS) was upgraded by analysts at Wall Stre
Kalaris Therapeutics (NASDAQ:KLRS) was downgraded by analysts at Wall St
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com